CURRICULUM VITAE
ACADEMIC QUALIFICATION
- MRCPCH, (CHILD HEALTH)Royal College of Paediatrics and Child Health
- M.D, (Medicine)Universiti Malaysia Sarawak (unimas)
MEMBERSHIPS
- ASIA PACIFIC PAEDIATRIC ENDOCRINE SOCIETY (APPES), MEMBER2020 to present (International)
- MALAYSIAN ENDOCRINE & METABOLIC SOCIETY (MEMS), MEMBER2018 to 2026 (National)
- MALAYSIAN MEDICAL ASSOCIATION (MMA), MEMBERSince 2002 (National)
PUBLICATIONS
Article in Journal
- Leong, A., & Vasanwala, R. F. (2024). Early Puberty Trend during the COVID-19 Pandemic in Singapore : A Retrospective Review in a Single Tertiary Centre. Journal of the ASEAN Federation of Endocrine Societies, 39(1), 6–11. https://doi.org/10.15605/jafes.039.01.12
RESEARCH PROJECT
International
- 2024 - 2029, Globe-RegGlobal Registry For Novel Therapies In Rare Bone & Endocrine Conditions (Globe-Reg), University of Glasgow, Scotland ( Co-Researcher)
- 2024 - 2027, Novo Nordisk Pharma (Malaysia) Sdn. BhdA Study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin as well as evaluating long term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
- 2024 - 2027, Novo Nordisk Pharma (Malaysia) Sdn. Bhd.A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
ACADEMIC/ PROF. SERVICES
Evaluation
- (2024) Reviewer, International, (Reviewer)
Contribution to External Organisation
- (2025) Data Access Committee, International, (Resource Person)